Mounjaro and Type 1 Diabetes: What People Are Asking

Mounjaro works as a dual GIP and GLP-1 receptor agonist — it acts on appetite-regulating pathways and, in people with type 2 diabetes, supports both blood-sugar management and weight reduction. Because of how these pathways function, the medicine's licensed use is specifically for adults with type 2 diabetes or obesity, where insulin resistance rather than absent insulin production is the core issue.

Why type 1 diabetes is a different picture

Type 1 diabetes involves the immune system attacking insulin-producing cells, meaning the body produces little or no insulin of its own. This is a fundamentally different mechanism from type 2 diabetes. Using a GLP-1 or dual GIP/GLP-1 medicine in someone with type 1 diabetes raises specific clinical considerations — including the risk of hypoglycaemia (low blood sugar), particularly if insulin doses are not carefully adjusted. These are not decisions anyone should make independently; they require close clinical supervision.

Similarly, Wegovy (semaglutide), a GLP-1 receptor agonist used in weight management, is not licensed for type 1 diabetes. Research into GLP-1 medicines and type 1 diabetes is ongoing, but licensed use remains in the type 2 and obesity space.

What this means if you are already prescribed Mounjaro

Some people on Mounjaro also live with insulin-treated or complex diabetes conditions. If that applies to you, your prescriber will be managing those interactions carefully. Any questions about how Mounjaro affects your blood sugar, your insulin regimen, or your diabetes management belong with your prescriber or doctor — not with a tracking app.

For a broader look at how Mounjaro is used in diabetes contexts, see our overview of Mounjaro and diabetes and using Mounjaro for diabetes management. For the full picture of the medicine itself, visit our Mounjaro information hub.

According to NHS guidance, tirzepatide is approved for use in adults with type 2 diabetes alongside diet and exercise, and suitability for any individual is assessed by a prescriber on a case-by-case basis.

GLP Trackr is a companion app for people already prescribed Mounjaro or Wegovy — it does not provide medical advice or make clinical decisions, but it does help you build a clear, organised record of your journey to share with your prescriber.

For anyone managing a complex condition alongside their GLP-1 medication, the app's side-effect and symptom tracker is particularly useful. You can log how you feel day by day — noting fatigue, dizziness, nausea, or any other changes — and see patterns emerge over time. That kind of organised record can make your appointments with a healthcare professional more productive, because you are bringing data rather than trying to recall weeks of experience from memory.

The doctor report feature pulls your logged data into a clear summary you can bring to your next clinical review — useful if your prescriber needs a detailed picture of how you have been responding to the medication.

GLP Trackr also logs each injection — dose strength, date, and time — so your treatment history is always at your fingertips. If you are curious about how Mounjaro intersects with other health conditions, you may also find our page on Mounjaro and endometriosis of interest as an example of how the medicine is being explored in different contexts.

Important: If you experience symptoms that concern you — including signs of low blood sugar such as shakiness, sweating, or confusion — contact your healthcare professional promptly. GLP Trackr helps you record your experience; it is not a substitute for clinical guidance, and any changes to your diabetes management must be made with your prescriber, never on your own.

Want to keep a detailed, organised record of your GLP-1 journey? GLP Trackr is free to start — download on the App Store or Google Play and explore everything with a 7-day free trial.